Date | Name | Title | Type | Security | Shares | Price | Value | Ownership | Reported |
06/30/2023 | ROSSI DINO A | Director | Grant | Stock Option (Right to Buy) | 6.8k | $117.40 | $798.3k | | 06/30/2023 |
06/30/2023 | JANNEY DANIEL | Director | Grant | Stock Option (Right to Buy) | 6.8k | $117.40 | $798.3k | | 06/30/2023 |
06/30/2023 | Gangolli Julian S | Director | Grant | Stock Option (Right to Buy) | 6.8k | $117.40 | $798.3k | | 06/30/2023 |
06/30/2023 | Mason Christopher | Director | Grant | Stock Option (Right to Buy) | 6.8k | $117.40 | $798.3k | | 06/30/2023 |
06/30/2023 | Sutherland Everett Rand | Director | Grant | Stock Option (Right to Buy) | 6.8k | $117.40 | $798.3k | | 06/30/2023 |
06/30/2023 | Mazzacco Catherine | Director | Grant | Stock Option (Right to Buy) | 2.2k | $117.40 | $255.9k | | 06/30/2023 |
06/09/2023 | ORTH ANDREW C. | Chief Commercial Officer | Sale | Common Stock | 5.3k | $128.10 | $674k | | 06/09/2023 |
06/09/2023 | ORTH ANDREW C. | Chief Commercial Officer | Sale | Common Stock | 6.9k | $128.94 | $890.5k | | 06/09/2023 |
06/09/2023 | ORTH ANDREW C. | Chief Commercial Officer | Sale | Common Stock | 333 | $129.70 | $43.2k | | 06/09/2023 |
06/09/2023 | ORTH ANDREW C. | Chief Commercial Officer | Exercise | Stock Option (Right to Buy) | 12.5k | $63.55 | $794.4k | | 06/09/2023 |
06/09/2023 | JANNEY DANIEL | Director | Sale | Common Stock | 3.9k | $129.29 | $508.8k | Directly beneficially owned by Alta Bioequities, L.P. | 06/08/2023 |
06/09/2023 | JANNEY DANIEL | Director | Sale | Common Stock | 5k | $128.84 | $644.2k | Directly beneficially owned by Alta Bioequities, L.P. | 06/08/2023 |
06/09/2023 | JANNEY DANIEL | Director | Sale | Common Stock | 10k | $128.53 | $1.3M | Directly beneficially owned by Alta Bioequities, L.P. | 06/08/2023 |
06/08/2023 | JANNEY DANIEL | Director | Sale | Common Stock | 4.6k | $127.96 | $589.1k | Directly beneficially owned by Alta Bioequities, L.P. | 06/08/2023 |
06/08/2023 | JANNEY DANIEL | Director | Sale | Common Stock | 1.1k | $129.02 | $138.4k | Directly beneficially owned by Alta Bioequities, L.P. | 06/08/2023 |
06/08/2023 | JANNEY DANIEL | Director | Sale | Common Stock | 5.4k | $128.73 | $693.6k | Directly beneficially owned by Alta Bioequities, L.P. | 06/08/2023 |
06/08/2023 | JANNEY DANIEL | Director | Sale | Common Stock | 5k | $127.96 | $639.8k | Directly beneficially owned by Alta Bioequities, L.P. | 06/08/2023 |
06/08/2023 | JANNEY DANIEL | Director | Sale | Common Stock | 10k | $127.96 | $1.3M | Directly beneficially owned by Alta Bioequities, L.P. | 06/08/2023 |
06/08/2023 | JANNEY DANIEL | Director | Sale | Common Stock | 5k | $127.86 | $639.3k | Directly beneficially owned by Alta Bioequities, L.P. | 06/08/2023 |
05/31/2023 | Krishnan Krish S | President and CEO | Sale | Common Stock | 18.9k | $116.00 | $2.2M | | 05/31/2023 |
05/31/2023 | Krishnan Krish S | President and CEO | Sale | Common Stock | 5.7k | $116.95 | $668.5k | | 05/31/2023 |
05/31/2023 | Krishnan Krish S | President and CEO | Sale | Common Stock | 400 | $117.61 | $47k | | 05/31/2023 |
05/31/2023 | Krishnan Krish S | President and CEO | Sale | Common Stock | 20.1k | $115.98 | $2.3M | By Spouse | 05/31/2023 |
05/31/2023 | Krishnan Krish S | President and CEO | Sale | Common Stock | 4.6k | $116.86 | $532.5k | By Spouse | 05/31/2023 |
05/31/2023 | Krishnan Krish S | President and CEO | Sale | Common Stock | 300 | $117.57 | $35.3k | By Spouse | 05/31/2023 |
05/31/2023 | Krishnan Suma | President, R&D | Sale | Common Stock | 20.1k | $115.98 | $2.3M | | 05/31/2023 |
05/31/2023 | Krishnan Suma | President, R&D | Sale | Common Stock | 4.6k | $116.86 | $532.5k | | 05/31/2023 |
05/31/2023 | Krishnan Suma | President, R&D | Sale | Common Stock | 300 | $117.57 | $35.3k | | 05/31/2023 |
05/31/2023 | Krishnan Suma | President, R&D | Sale | Common Stock | 18.9k | $116.00 | $2.2M | By Spouse | 05/31/2023 |
05/31/2023 | Krishnan Suma | President, R&D | Sale | Common Stock | 5.7k | $116.95 | $668.5k | By Spouse | 05/31/2023 |
05/31/2023 | Krishnan Suma | President, R&D | Sale | Common Stock | 400 | $117.61 | $47k | By Spouse | 05/31/2023 |
05/22/2023 | Romano Kathryn | Chief Accounting Officer | Sale | Common Stock | 2.5k | $105.80 | $266.7k | | 05/19/2023 |
05/22/2023 | Romano Kathryn | Chief Accounting Officer | Sale | Common Stock | 2.6k | $106.81 | $274.5k | | 05/19/2023 |
05/22/2023 | Romano Kathryn | Chief Accounting Officer | Sale | Common Stock | 1.3k | $107.88 | $140.2k | | 05/19/2023 |
05/22/2023 | Romano Kathryn | Chief Accounting Officer | Sale | Common Stock | 3k | $109.17 | $322.6k | | 05/19/2023 |
|